Agonist-induced activation of PPARγ in a colon cancer xenograft model showed reduction of tumor growth [14], whereas it resulted in tumor promotion when PPARγ was activated in a genetic model of colon cancer (APCMin mice) [15,16]. Here, PPARG is linked to malignant colon neoplasm.